genai / news / / Euronews
OpenAI has launched a new artificial intelligence model designed to support research across biology, drug discovery, and translational medicine.
OpenAI launched GPT‑Rosalind, a life sciences AI model optimized for biological and medical research tasks.
KEY POINTS
- GPT‑Rosalind excels at reasoning over molecules, proteins, genes, pathways, and disease-relevant biology.
- The model demonstrates advanced capabilities in multi-step scientific workflows, including experimental planning and data analysis.
- OpenAI is partnering with companies like Moderna, Amgen, and Novo Nordisk to deploy GPT‑Rosalind in R&D and manufacturing.
- Full integration of GPT‑Rosalind pilot programs with partners is targeted by the end of the year.
COMPANIES
Summarized by Newsio from Euronews. How we summarize →